Correlia Biosystems
San Francisco
About Correlia Biosystems
Correlia Biosystems develops microscale tools that accelerate the rate of molecular interactions, allowing for measurements of biomolecules. Correlia Biosystems is a UC Berkeley spinoff that creates protein measurement tools that are inexpensive, quick, and customizable. Their adaptable SimpleScan technology has a wide range of applications, from point-of-care diagnostics to rapid and multiplexed proteomics research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.7M
- Last round: Series Unknown (Oct 2020)
- Website: correliabio.com
- Phone: 3109023612
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/correlia-biosystems-89834 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.